GLP-1 Study Finds Differences in Lean Mass Loss GLP-1 study reports semaglutide preserved lean mass better than tirzepatide, with a 2% higher lean mass loss on tirzepatide over 12 months. 28 Apr 2026 #GLP1#Semaglutide#Tirzepatide#MuscleMass#WeightLoss
